Health
Why Moderna Stock Climbed Today – Motley Fool
One analyst sees gains of nearly 40% ahead for the biotech’s shareholders.
What happened
Shares of Moderna (NASDAQ:MRNA) rose 6.8% on Friday, as analysts and investors grew more optimistic about the vaccine maker’s growth prospects.
So what
Piper Sandler analyst Edward Tenthoff repeated his overweight rating on Moderna’s stock and boosted his price forecast from $208 to $234 on Thursday. His new price target represents potential returns to shareholders of roughly 37% from Moderna’s current share price near $170.
Moderna’s stock price is up sharply in recent days. Image…
-
General11 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News17 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General23 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
General13 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery